Health
Metformin use reduces risk of death for patients with COVID-19 and diabetes – Medical Xpress
Use of the diabetes drug metformin—before a diagnosis of COVID-19—is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metforminbefore a diagnosis of COVID-19is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive Diabetes…
-
General14 hours agoInjured former Greens candidate Hannah Thomas charged with hindering or resisting police at pro-Palestinian protest
-
General13 hours agoTony Burke’s detention inaction | The Spectator Australia
-
General16 hours agoTasmania’s business lobby backing Labor’s budget savings measures, as Liberals launch state election campaign
-
General16 hours agoIf Iran’s regime fell tomorrow, Iranians wouldn’t be united on what comes next